Genomics medicine company NantHealth plans to file an initial public offering by the end of the year, according to a Los Angeles Times report.
The announcement from NantHealth follows news that Allscripts invested $200 million for a 10 percent stake in NantHealth, bringing the value of NantHealth to $2 billion.
Patrick Soon-Shiong, MD, founder of NantHealth, said Allscripts' investment was critical to NantHealth's plan to go public.
"We feel we have one or two transactions to accomplish, then we will initiate the public offering that we anticipate will happen probably within this year," Dr. Soon-Shiong told the LA Times. "We're setting the infrastructure so when we're in the public world we can really execute."
More articles on health IT:
Cerner, McKesson named Best Places to Work in IT; Epic and Nebraska Medicine use Apple Watch for patient engagement; McKesson names CIO, CTO — 7 health IT company key notes
First-time MU hospitals can now attest this summer
8 recent vendor contracts, go-lives